EUVIMEDEUVIMED entdecken
Crossref

A Dual-Targeted, Long-Circulating, and Intelligent-Responsive Antiviral Agent Suppresses SARS-CoV-2 by Blocking Viral Entry and Replication

Jingyang Zhao, Peng Ye, Huatai Zhu, Yucheng Li, Jiandu Lei iD

Bioconjugate Chemistry · 2026

DOI: 10.1021/acs.bioconjchem.5c00482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Jingyang Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, China Academy of Sciences, Beijing 100190, Chin…. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Virus Replication, Virus Internalization. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Various natural drugs such as glycyrrhizic acid (GA), hesperidin (Hes), and baicalin (Bai) exhibit anti-SARS-CoV-2 potential but suffer from poor water solubility, short half-life, and low binding capacity to viral targets. Hence, a dual-targeted, long-circulating, ROS-responsive, and broad-spectrum antiviral inhibitor (mPAGHB) is designed through a strategy of "polymer-drug linkage". The mPAGHB suppresses SARS-CoV-2 through two "lines of defense", including extracellular inhibition of the "spike protein-angiotensin converting enzyme 2 (ACE2)" process and intracellular inhibition of the enzymatic activity of major protease. It exhibits higher affinity for spike protein (KD = 4.95 × 10-2 μM), excellent inhibition of Mpro activity (76.27 ± 5.94% inhibition), and improved inhibition for pseudovirus of SARS-CoV-2 and Omicron variants in cellular and animal assays. In addition, as an efficient generic strategy, the "polymer-drug linkage" strategy facilitates the rapid construction of antiviral inhibitors based on natural active ingredients for the outbreaks of viral public infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2Virus ReplicationVirus InternalizationCOVID-19 Drug TreatmentHumansAnimalsSpike Glycoprotein, CoronavirusVero CellsAngiotensin-Converting Enzyme 2COVID-19Chlorocebus aethiops

Substanzen

Antiviral AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Angiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, China Academy of Sciences, Beijing 100190, China.
  • Beijing Key Laboratory of Lignocellulosic Chemistry, Beijing Forestry University, Beijing 100083, China.
  • MOE Engineering Research Center of Forestry Biomass Materials and Bioenergy, Beijing Forestry University, Beijing 100083, China.

ORCID-Profile: Jiandu Lei

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, J., Ye, P., Zhu, H., Li, Y., & Lei, J. (2026). A Dual-Targeted, Long-Circulating, and Intelligent-Responsive Antiviral Agent Suppresses SARS-CoV-2 by Blocking Viral Entry and Replication. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00482

Vancouver

Zhao J, Ye P, Zhu H, Li Y, Lei J. A Dual-Targeted, Long-Circulating, and Intelligent-Responsive Antiviral Agent Suppresses SARS-CoV-2 by Blocking Viral Entry and Replication. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.5c00482

BibTeX
@article{Zhao2026,
  author = {Zhao, Jingyang and Ye, Peng and Zhu, Huatai and Li, Yucheng and Lei, Jiandu},
  title = {A Dual-Targeted, Long-Circulating, and Intelligent-Responsive Antiviral Agent Suppresses SARS-CoV-2 by Blocking Viral Entry and Replication},
  journal = {Bioconjugate Chemistry},
  year = {2026},
  doi = {10.1021/acs.bioconjchem.5c00482}
}
Kostenlos starten →